These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20091064)

  • 41. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant.
    Caso F; Canu E; Lukic MJ; Petrovic IN; Fontana A; Nikolic I; Kostic VS; Filippi M; Agosta F
    J Neurol; 2020 Jan; 267(1):87-94. PubMed ID: 31559533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. State anxiety predicts cognitive performance in patients with Parkinson's disease.
    Ehgoetz Martens KA; Silveira CRA; Intzandt BN; Almeida QJ
    Neuropsychology; 2018 Nov; 32(8):950-957. PubMed ID: 30284873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Depression and anxiety in multiple system atrophy.
    Zhang LY; Cao B; Zou YT; Wei QQ; Ou RW; Zhao B; Wu Y; Shang HF
    Acta Neurol Scand; 2018 Jan; 137(1):33-37. PubMed ID: 28748633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tonic Electromyogram Density in Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease.
    Wang Y; Shen Y; Xiong KP; He PC; Mao CJ; Li J; Wang FY; Wang YL; Huang JY; Liu CF
    Chin Med J (Engl); 2017 Mar; 130(6):684-690. PubMed ID: 28303851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy.
    Péran P; Barbagallo G; Nemmi F; Sierra M; Galitzky M; Traon AP; Payoux P; Meissner WG; Rascol O
    Mov Disord; 2018 Apr; 33(4):600-608. PubMed ID: 29473662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT; Longo K; Manfredi M; Lucetti C; Cossu G; Petrone A; Marconi R; Sensi M; Epifanio A; Eleopra R; Marchese R; Scaravilli T; Morgante L; Abbruzzese G; Bonuccelli U; Donati E; Pivonello R; Colao A; Barone P
    Mov Disord; 2008 Jan; 23(2):190-4. PubMed ID: 18044703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular responses during cold pressor test are different in Parkinson disease and multiple system atrophy with parkinsonism.
    Roy S; Srivastava AK; Jaryal AK; Deepak KK
    Clin Auton Res; 2015 Aug; 25(4):219-24. PubMed ID: 26220575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apraxia in Parkinson's disease and multiple system atrophy.
    Uluduz D; Ertürk O; Kenangil G; Ozekmekçi S; Ertan S; Apaydin H; Erginöz E
    Eur J Neurol; 2010 Mar; 17(3):413-8. PubMed ID: 20050896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy.
    Brisinda D; Sorbo AR; Di Giacopo R; Venuti A; Bentivoglio AR; Fenici R
    J Neurol Sci; 2014 Jan; 336(1-2):197-202. PubMed ID: 24267739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration.
    Chang CC; Chang YY; Chang WN; Lee YC; Wang YL; Lui CC; Huang CW; Liu WL
    Eur J Neurol; 2009 Oct; 16(10):1144-50. PubMed ID: 19486137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes.
    Zhang L; Cao B; Ou R; Wei QQ; Zhao B; Yang J; Wu Y; Shang H
    Parkinsonism Relat Disord; 2017 Feb; 35():63-68. PubMed ID: 27993522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage.
    Baschieri F; Calandra-Buonaura G; Doria A; Mastrolilli F; Palareti A; Barletta G; Solieri L; Guaraldi P; Martinelli P; Cortelli P
    Parkinsonism Relat Disord; 2015 May; 21(5):477-82. PubMed ID: 25749354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonmotor Features in Atypical Parkinsonism.
    Bhatia KP; Stamelou M
    Int Rev Neurobiol; 2017; 134():1285-1301. PubMed ID: 28805573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
    Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
    Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Red flags for multiple system atrophy.
    Köllensperger M; Geser F; Seppi K; Stampfer-Kountchev M; Sawires M; Scherfler C; Boesch S; Mueller J; Koukouni V; Quinn N; Pellecchia MT; Barone P; Schimke N; Dodel R; Oertel W; Dupont E; Østergaard K; Daniels C; Deuschl G; Gurevich T; Giladi N; Coelho M; Sampaio C; Nilsson C; Widner H; Sorbo FD; Albanese A; Cardozo A; Tolosa E; Abele M; Klockgether T; Kamm C; Gasser T; Djaldetti R; Colosimo C; Meco G; Schrag A; Poewe W; Wenning GK;
    Mov Disord; 2008 Jun; 23(8):1093-9. PubMed ID: 18442131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up study.
    Jecmenica-Lukic MV; Pekmezovic TD; Petrovic IN; Dragasevic NT; Kostić VS
    Acta Neurol Belg; 2018 Dec; 118(4):589-595. PubMed ID: 29949032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.